DE2804566C2 - Arginyl-Lysyl-Aspartyl-Valyl-Tyrosin und dessen Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung - Google Patents

Arginyl-Lysyl-Aspartyl-Valyl-Tyrosin und dessen Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Info

Publication number
DE2804566C2
DE2804566C2 DE2804566A DE2804566A DE2804566C2 DE 2804566 C2 DE2804566 C2 DE 2804566C2 DE 2804566 A DE2804566 A DE 2804566A DE 2804566 A DE2804566 A DE 2804566A DE 2804566 C2 DE2804566 C2 DE 2804566C2
Authority
DE
Germany
Prior art keywords
cells
acid
resin
pentapeptide
thymus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2804566A
Other languages
German (de)
English (en)
Other versions
DE2804566A1 (de
Inventor
Gideon Short Hills N.J. Goldstein
David H. Lombard Ill. Schlesinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sloan Kettering Institute for Cancer Research
Original Assignee
Sloan Kettering Institute for Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Institute for Cancer Research filed Critical Sloan Kettering Institute for Cancer Research
Publication of DE2804566A1 publication Critical patent/DE2804566A1/de
Application granted granted Critical
Publication of DE2804566C2 publication Critical patent/DE2804566C2/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/66—Thymopoietins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE2804566A 1977-11-15 1978-02-03 Arginyl-Lysyl-Aspartyl-Valyl-Tyrosin und dessen Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung Expired DE2804566C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85177777A 1977-11-15 1977-11-15

Publications (2)

Publication Number Publication Date
DE2804566A1 DE2804566A1 (de) 1979-05-17
DE2804566C2 true DE2804566C2 (de) 1986-01-16

Family

ID=25311654

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2804566A Expired DE2804566C2 (de) 1977-11-15 1978-02-03 Arginyl-Lysyl-Aspartyl-Valyl-Tyrosin und dessen Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Country Status (7)

Country Link
JP (2) JPS5476543A (ko)
BE (1) BE864121A (ko)
CA (1) CA1105925A (ko)
CH (1) CH639941A5 (ko)
DE (1) DE2804566C2 (ko)
FR (1) FR2408580A1 (ko)
SE (1) SE446867B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215112A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Tripeptides and methods
US4215111A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Peptides having ubiquitin-like activity
ZA802170B (en) * 1979-04-12 1981-11-25 Ortho Pharma Corp Peptides having thymopoietin-like activity
DE2938420A1 (de) * 1979-09-22 1981-04-09 Hoechst Ag, 6000 Frankfurt Neue peptide und verfahren zu ihrer herstellung
US4426324A (en) * 1979-09-28 1984-01-17 Hoffmann-La Roche Inc. Immunopotentiating peptides
US4298523A (en) * 1980-06-17 1981-11-03 Ortho Pharmaceutical Corporation Methods and compositions for preparation of H-ARG-X-Z-Y-TYR-R
DE3401545A1 (de) * 1983-08-03 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue peptide mit immunstimulierender wirkung, verfahren zu deren herstellung und deren verwendung
US4629723A (en) * 1984-06-27 1986-12-16 Ortho Pharmaceutical Corporation Potent thymopentin analogs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002740A (en) * 1975-08-21 1977-01-11 Gideon Goldstein Tridecapeptide compositions and methods

Also Published As

Publication number Publication date
CH639941A5 (en) 1983-12-15
DE2804566A1 (de) 1979-05-17
JPS6150998A (ja) 1986-03-13
BE864121A (fr) 1978-08-21
JPS6118560B2 (ko) 1986-05-13
FR2408580B1 (ko) 1983-01-07
SE446867B (sv) 1986-10-13
JPS5476543A (en) 1979-06-19
SE7801030L (sv) 1979-05-16
JPH0137399B2 (ko) 1989-08-07
FR2408580A1 (fr) 1979-06-08
CA1105925A (en) 1981-07-28

Similar Documents

Publication Publication Date Title
EP0028627B1 (de) Verfahren zur herstellung von thymosin-alpha1 und derivaten davon
DE2813327C2 (ko)
DE3211263C2 (ko)
US4190646A (en) Polypeptide compositions and methods
US4002740A (en) Tridecapeptide compositions and methods
DE2804566C2 (de) Arginyl-Lysyl-Aspartyl-Valyl-Tyrosin und dessen Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0502874A1 (de) Neue vom neuropeptid y abgeleitete peptide
EP0292729B1 (de) Neue Festphasen-Peptidsynthesemethoden
EP0016612B1 (en) Peptides having ubiquitin-like activity, process for their preparation, therapeutic compositions containing them and their use
EP0075776B1 (de) Bis-thymosin Alpha 1-Verbindungen
EP0249169A2 (de) Peptide mit Einfluss auf die Diurese und Natriurese, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und ihre Verwendung
DE2804567C2 (de) Pentapeptide, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0135722B1 (de) Neue Peptide mit immunstimulierender Wirkung, Verfahren zu deren Herstellung und deren Verwendung
DE2718718A1 (de) Somatostatinanaloge und zwischenprodukte hierzu
DE3014582C2 (ko)
EP0117447B1 (de) Cyclische Peptide mit Somatostatin-Wirkung
CH642058A5 (de) Polypeptide sowie diese polypeptide enthaltende arzneimittel.
EP0056594B1 (de) Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunregulierender Wirkung und Thymosin-alpha-1-Fragmente
EP0307553B1 (de) Modifizierte Splenopentine, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0095557B1 (de) Polypeptide mit antagonistischen Eigenschaften gegenüber der Substanz P, Verfahren zu ihrer Herstellung, deren Verwendung und Verfahren zum Reinigen von Polypeptiden
DE2628006C2 (de) Tridecapeptid, Verfahren zu seiner Herstellung und seine Verwendung
DE3146598A1 (de) "neue peptide und verfahren zu ihrer herstellung"
US4258152A (en) Pentapeptide modified resin
DD296084A5 (de) Verfahren zur herstellung von humanen spleninderivaten
DE4014230A1 (de) Bombesin-antagonisten

Legal Events

Date Code Title Description
OAP Request for examination filed
OD Request for examination
D2 Grant after examination
8364 No opposition during term of opposition